Acumen Pharmaceuticals Ownership | Who Owns Acumen Pharmaceuticals?
Acumen Pharmaceuticals Ownership Summary
Acumen Pharmaceuticals is owned by 27.24% institutional investors, 11.41% insiders, and 61.34% retail investors. Ra capital management is the largest institutional shareholder, holding 24.67% of ABOS shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 2.44% of its assets in Acumen Pharmaceuticals shares.
ABOS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Acumen Pharmaceuticals | 27.24% | 11.41% | 61.34% |
| Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 14.93M | 24.67% | $16.43M |
| Sands capital ventures | 3.42M | 5.69% | $5.88M |
| Franklin resources | 3.27M | 5.45% | $5.63M |
| Blackrock funding, inc. /de | 2.37M | 3.95% | $4.08M |
| Blackrock | 2.16M | 3.61% | $5.22M |
| Fmr | 2.02M | 3.37% | $3.48M |
| Vanguard group | 1.94M | 3.23% | $3.34M |
| Knollwood investment advisory | 1.63M | 2.71% | $2.80M |
| Millennium management | 1.14M | 1.88% | $1.25M |
| Alyeska investment group | 939.60K | 1.56% | $1.62M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sands capital ventures | 3.42M | 1.28% | $5.88M |
| Knollwood investment advisory | 1.63M | 0.29% | $2.80M |
| Ra capital management | 14.93M | 0.27% | $16.43M |
| Ikarian capital | 265.77K | 0.04% | $292.35K |
| Adar1 capital management | 146.18K | 0.03% | $160.80K |
| Catalyst financial partners | 89.70K | 0.03% | $154.28K |
| Laurion capital management lp | 867.05K | 0.03% | $1.49M |
| Intrepid financial planning group | 30.15K | 0.02% | $51.86K |
| Alyeska investment group | 939.60K | 0.01% | $1.62M |
| Bridgeway capital management | 134.00K | 0.01% | $230.48K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 2.16M | 0.00% | 1.97M |
| Jpmorgan chase | 937.91K | 0.00% | 874.84K |
| Ubs group | 141.49K | - | 118.74K |
| Pathstone | 606.85K | 0.00% | 89.56K |
| Deutsche bank ag\ | 97.00K | 0.00% | 79.94K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rock springs capital management lp | - | - | -1.84M |
| Price t rowe associates inc /md/ | 13.62K | - | -836.00K |
| Parkman healthcare partners | - | - | -576.66K |
| Franklin resources | 3.27M | 0.00% | -275.44K |
| Tang capital management | - | - | -246.90K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Intech investment management | 18.85K | 0.00% | 18.85K | $32.42K |
| Vanguard personalized indexing management | 12.89K | 0.00% | 12.89K | $22.18K |
| Squarepoint ops | 11.81K | - | 11.81K | $20.32K |
| Integrated wealth concepts | 10.10K | 0.00% | 10.10K | $17.37K |
| Bnp paribas arbitrage, snc | 7.02K | - | 7.02K | $12.07K |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -52.00 |
| Nisa investment advisors | -356.00 |
| Redwood wealth management group | -800.00 |
| Kelly financial services | -944.00 |
| Macquarie group | -1.25K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 5 | -93.83% | 16,490,041 | -61.19% | 27 | 0.54% | 1 | -97.50% | 2 | -90.00% |
| Dec 31, 2024 | 81 | 5.19% | 42,494,401 | -2.55% | 70 | 1.34% | 40 | 17.65% | 20 | -4.76% |
| Sep 30, 2024 | 77 | -10.47% | 43,605,266 | 0.06% | 72 | 1.37% | 34 | -24.44% | 21 | 10.53% |
| Jun 30, 2024 | 86 | 2.38% | 43,581,297 | 0.50% | 72 | 1.30% | 45 | -8.16% | 19 | -13.64% |
| Mar 31, 2024 | 84 | 16.67% | 43,366,076 | 12.88% | 74 | 1.49% | 49 | 4.26% | 22 | 144.44% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Franklin Biotechnology Discv A(acc)USD | 1.48M | 2.44% | - |
| Franklin Small Cap Growth SMA | 1.19M | 1.98% | 1.19M |
| Vanguard Total Stock Mkt Idx Inv | 1.15M | 1.89% | - |
| Fidelity Select Health Care | 1.14M | 1.88% | - |
| iShares Russell 2000 ETF | 992.38K | 1.64% | 486.00 |
| Franklin Biotechnology Discovery A | 826.40K | 1.36% | - |
| Franklin Small Cap Growth Adv | 767.97K | 1.27% | - |
| Franklin US Small Cap Growth Equity | 767.97K | 1.27% | -128.22K |
| Fidelity Advisor Health Care I | 700.00K | 1.16% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 472.17K | 0.78% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 21, 2025 | Zuga Matt | CFO & Chief Business Officer | Sell | $6.99K |
| Jan 23, 2025 | Zuga Matt | CFO & Chief Business Officer | Sell | $49.63K |
| Jan 21, 2025 | OConnell Daniel Joseph | Chief Executive Officer | Sell | $20.10K |
| Jan 21, 2025 | Meisner Derek M | Chief Legal Officer & Corp Sec | Sell | $5.43K |
| Jan 21, 2025 | Barton Russell | Chief Operating Officer | Sell | $4.69K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | 11 |
| 2024 Q4 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | 5 |
ABOS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools